---
figid: PMC11040305__NRR-19-1877-g001
pmcid: PMC11040305
image_filename: NRR-19-1877-g001.jpg
figure_link: /pmc/articles/PMC11040305/figure/F1/
number: Figure 1
figure_title: ''
caption: 'Drug candidates targeting Aβ and/or tau or facilitating degradation via
  the ALP.The drugs listed in the three circles are currently in clinical trials.
  The molecular tweezer CLR01 (Shahpasand-Kroner et al., 2023) in the middle has been
  shown preclinically to target all three mechanisms. Created using Adobe Illustrator.
  Aβ: Amyloid-β; ALP: autophagy-lysosomal pathway.'
article_title: Recent advances and future therapy development for Alzheimer's disease
  and related disorders.
citation: Megan Hong, et al. Neural Regen Res. 2024 Sep;19(9):1877-1878.
year: '2024'

doi: 10.4103/1673-5374.391182
journal_title: Neural Regeneration Research
journal_nlm_ta: Neural Regen Res
publisher_name: Wolters Kluwer - Medknow

keywords:
---
